Evidence map›Paper›PMID 28292147›Full record

ArticleThe Pan African medical journal2016

[Seroprevalence of viral markers among blood donors at the Blood Donor Center of Mohammed V Military Teaching Hospital of Rabat, Morocco].

Jean Uwingabiye, Hafidi Zahid, Loubet Unyendje, Rachid Hadef

Open access · goldAbstract read
In one paragraph

Article in The Pan African medical journal, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jean UwingabiyeCentre de Transfusion Sanguine, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V, Rabat, Maroc.
Hafidi ZahidCentre de Transfusion Sanguine, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V, Rabat, Maroc.
Loubet UnyendjeCentre de Transfusion Sanguine, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V, Rabat, Maroc.
Rachid HadefCentre de Transfusion Sanguine, Hôpital Militaire d'Instruction Mohammed V de Rabat, Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V, Rabat, Maroc.
Mohammed V University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aims to determine the prevalence of human immunodeficiency virus (HIV) infections and hepatitis B virus (HBV) and hepatitis C virus (HCV) infections among blood donors at the Blood Donor Center, Mohammed V Military Teaching Hospital between 2010 and 2012. We conducted a retrospective study among military blood donors aged 18-50 years, with a male predominance (95%). Pre-donation interview is the first selection barrier for individuals at risk. Biological screening was performed by liquid enzyme immunoassay technique using antibodies and/or antigen. Fourth generation combined HCV and HIV antigen/antibody ELISA (enzyme-linked immunosorbent assay) test was used. The Blood Donor Center and the laboratory of virology used the same technique performed in duplicate to confirm results. Out of 25661 tested samples, the prevalence rate of HBV infections was 3.97 ‰ (n = 102), the prevalence rate of HCV infections was 2.45 ‰ (n = 63) and the prevalence rate of HIV infections was 0.15 ‰ (n = 4). A single case with HBV and HCV virus co-infection (0.039 ‰) was registered, no association between HIV-HBV, HIV-HCV or HBV, HCV and HIV infections was recorded. The low seroprevalence rates of viral markers recorded in our study show improvement in preventive measures for donor selection and screening tests. The registered prevalence encourages the use of combined reagent, which is the only alternative to molecular biology in developing countries.

Indexed as

Blood DonorsAdolescentAdultBiomarkersCoinfectionEnzyme-Linked Immunosorbent AssayFemaleHepatitis BHepatitis B AntibodiesHepatitis CHepatitis C AntibodiesHIV AntibodiesHIV InfectionsHospitals, MilitaryHospitals, TeachingHumansBiomarkersHepatitis B AntibodiesHepatitis C AntibodiesHIV Antibodiesblood donationHBVHCVHIVSeroprevalence

Identifiers

PMID28292147
PMCPMC5326047
OpenAlexW2552118679

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.